ConductScience.org, home

Paper37242533

Effects of Lipid-Modifying and Other Drugs on Lipoprotein(a) Levels-Potent Clinical Implications.

Koutsogianni AD and 4 others. Pharmaceuticals (Basel), 2023. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Effects of Lipid-Modifying and Other Drugs on Lipoprotein(a) Levels-Potent Clinical Implications. Papers, record 37242533. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37242533

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of Lipid-Modifying and Other Drugs on Lipoprotein(a) Levels-Potent Clinical Implications.
PubMed
Journal
Pharmaceuticals (Basel)
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
2.48
iCite
Revised in PubMed
2023-05-30
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Koutsogianni ADAmalia Despoina
2Liamis GGeorge
3Liberopoulos EEvangeloshttps://orcid.org/0000-0002-7162-3323
4Adamidis PSPetros Spyridonas
5Florentin MMatildahttps://orcid.org/0000-0002-0135-9694

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Athens, July 6, 2021, Protocol Number 514 Φ/4Hellenic Atherosclerosis SocietyPubMed

Source PubMed

Download CSV of grants

References109

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136764050Trends and consequences of lipoprotein(a) testing: Cross-sectional and longitudinal health insurance claims database analyses.Atherosclerosis2023https://conductscience.org/library/papers/36764050PubMed
232187462Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol.N Engl J Med2020https://conductscience.org/library/papers/32187462PubMed
325014686Effects of extended-release niacin with laropiprant in high-risk patients.N Engl J Med2014https://conductscience.org/library/papers/25014686PubMed
428454801
Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)-A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitment, and baseline characteristics.
Am Heart J2017https://conductscience.org/library/papers/28454801PubMed
530293769Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials.Lancet2018https://conductscience.org/library/papers/30293769PubMed
634172394Lipid lowering with bempedoic acid added to a proprotein convertase subtilisin/kexin type 9 inhibitor therapy: A randomized, controlled trial.J Clin Lipidol2021https://conductscience.org/library/papers/34172394PubMed
724754313
Reductions in serum levels of LDL cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in hypercholesterolaemic patients treated with the liver-selective thyroid hormone receptor agonist eprotirome.
J Intern Med2015https://conductscience.org/library/papers/24754313PubMed
822516069Genetic evidence that lipoprotein(a) associates with atherosclerotic stenosis rather than venous thrombosis.Arterioscler Thromb Vasc Biol2012https://conductscience.org/library/papers/22516069PubMed
927206939Evacetrapib alone or in combination with statins lowers lipoprotein(a) and total and small LDL particle concentrations in mildly hypercholesterolemic patients.J Clin Lipidol2016https://conductscience.org/library/papers/27206939PubMed
1024161338Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population.J Am Coll Cardiol2014https://conductscience.org/library/papers/24161338PubMed
1130561610
Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatment.
Eur Heart J2019https://conductscience.org/library/papers/30561610PubMed
1231130489Impact of PCSK9 inhibitors on plasma lipoprotein(a) concentrations with or without a background of niacin therapy.J Clin Lipidol2019https://conductscience.org/library/papers/31130489PubMed
1325614280Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials.Arterioscler Thromb Vasc Biol2015https://conductscience.org/library/papers/25614280PubMed
1425490294[Long-term follow-up in patients with homozygous familial hypercholesterolemia; 13-year experience of a university hospital lipid clinic].Turk Kardiyol Dern Ars2014https://conductscience.org/library/papers/25490294PubMed
1535163026Development of Thyroid Hormones and Synthetic Thyromimetics in Non-Alcoholic Fatty Liver Disease.Int J Mol Sci2022https://conductscience.org/library/papers/35163026PubMed
1629071331Association of Lipoprotein(a) With Risk of Recurrent Ischemic Events Following Acute Coronary Syndrome: Analysis of the dal-Outcomes Randomized Clinical Trial.JAMA Cardiol2018https://conductscience.org/library/papers/29071331PubMed
1710336452Estrogen modulation of apolipoprotein(a) expression. Identification of a regulatory element.J Biol Chem1999https://conductscience.org/library/papers/10336452PubMed
1818775538Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy.Atherosclerosis2009https://conductscience.org/library/papers/18775538PubMed
1925014706Safety profile of extended-release niacin in the AIM-HIGH trial.N Engl J Med2014https://conductscience.org/library/papers/25014706PubMed
2076795045' control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/7679504PubMed

See all 109 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
42643372Lipoprotein(a) in cardiovascular disease: pathophysiology, residual risk, and emerging therapeutic strategies.Front Med (Lausanne)2026https://conductscience.org/library/papers/42643372PubMed
42553348Lipoprotein (a) and inflammatory bowel disease: a systematic review and meta-analysis.Ann Gastroenterol2026https://conductscience.org/library/papers/42553348PubMed
42152281Zerlasiran for Lipoprotein(a) Reduction: Mechanisms, Evidence, and Future Directions.Cardiovasc Hematol Disord Drug Targets2026https://conductscience.org/library/papers/42152281PubMed
41612460Hepatic targeting in ASCVD: integrating lipid lowering and inflammation modulation from statins to gene editing.J Transl Med2026https://conductscience.org/library/papers/41612460PubMed
40944095Ethnic Variation in Lipoprotein(a) Levels in the Kazakhstan Population.J Clin Med2025https://conductscience.org/library/papers/40944095PubMed
40083956Valvular calcification in chronic kidney disease: new insights from recent clinical and preclinical studies.Clin Kidney J2025https://conductscience.org/library/papers/40083956PubMed
39867207Statins-Their Effect on Lipoprotein(a) Levels.Rev Cardiovasc Med2025https://conductscience.org/library/papers/39867207PubMed
39855644Lipid-lowering and antihypertensive drugs on aortic disease risk: insights from Mendelian randomization analysis and real-world pharmacovigilance data.Eur Heart J Cardiovasc Pharmacother2025https://conductscience.org/library/papers/39855644PubMed
39781530Lipoprotein(a) and Atrial Fibrillation: Mechanistic Insights and Therapeutic Approaches.Int J Med Sci2025https://conductscience.org/library/papers/39781530PubMed
39776103The impact of tamoxifen on apolipoproteins and lipoprotein(a) levels: an updated meta-analysis of randomized controlled trials.Endocrine2025https://conductscience.org/library/papers/39776103PubMed
38927436The Role of Lipoprotein(a) in Peripheral Artery Disease.Biomedicines2024https://conductscience.org/library/papers/38927436PubMed
38542510Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?Int J Mol Sci2024https://conductscience.org/library/papers/38542510PubMed
38535096Neutrophil Extracellular Traps (NETs) and Atherosclerosis: Does Hypolipidemic Treatment Have an Effect?J Cardiovasc Dev Dis2024https://conductscience.org/library/papers/38535096PubMed
37887316Lipoprotein(a)-60 Years Later-What Do We Know?Cells2023https://conductscience.org/library/papers/37887316PubMed
37668953Treatment of Lp(a): Is It the Future or Are We Ready Today?Curr Atheroscler Rep2023https://conductscience.org/library/papers/37668953PubMed
37371756Evidence and Uncertainties on Lipoprotein(a) as a Marker of Cardiovascular Health Risk in Children and Adolescents.Biomedicines2023https://conductscience.org/library/papers/37371756PubMed

Download CSV of cited by

Genes13

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37242533

GET https://conductscience.org/api/papers/v1/37242533/references?page=2